Scie-Plas™ Green Range™ horizontal gel electrophoresis units offer the ultimate standards in innovative design and manufacture, acquired during our 20-year existence. The Scie-Plas Green Range horizontal gel electrophoresis units currently comprise models with gel tray sizes ranging from 6 x 7.5 to 25 x 30cm. All models incorporate many design and safety features recommended by scientists, either from within our in-house product development team or laboratories worldwide. As a result, all our models are manufactured and finished to the highest specification, easy to use, and, with safety always paramount, CE-marked - conforming to European safety regulations.
The HU13 Midi horizontal gel unit is ideal for routine preparatory and analytical electrophoresis techniques. It has a maximum 112-sample throughput capacity and features a removable gel-casting tray with end gaskets that allow gels to be cast directly within the tank. The gel-casting tray is simply turned at 90° to the direction of electrophoresis, when the end gaskets form a leak proof seal against the inner walls of the running chamber. Once the gel has set and is ready for loading, the gel-casting tray is then restored to its correct orientation in the direction of electrophoresis.
Alternatively, single gels may be cast outside of the tank using HU13-SCG silicone casting gates or HU13-SS Scie-Plas Super-Seals, while a further 2 gels may be cast simultaneously within the HU13-CU midi-gel external casting unit.
Complete System Midi horizontal gel unit with removable casting tray and 2 x 1mm thick, 16-sample combs, coloured loading strips and buffer recirculation ports Unit Dimensions (W x L x H): 20 x 32 x 7cm Gel Dimensions (W x L): 12.8 x 15cm Buffer Volume: 900ml Maximum Sample Capacity: 112 Recommended Power Supplies: Consort EV243
Retractable Protein Nanoneedles The ability to control the transfer of molecules through cellular membranes is an important function in synthetic biology; a new study from researchers at Harvard’s Wyss Institute for Biologically Inspired Engineering and Harvard Medical School (HMS) introduces a novel mechanical method for controlling release of molecules inside cells.A Crystal Clear View of Biomolecules Fundamental discovery triggers paradigm shift in crystallography.Charting Kidney Cancer Metabolism Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy."Dark Side" of the Transcriptome New approach to quantifying gene "read-outs" reveals important variations in protein synthesis and has implications for understanding neurodegenerative diseases.Advancing Synthetic Biology Living systems rely on a dizzying variety of chemical reactions essential to development and survival. Most of these involve a specialized class of protein molecules — the enzymes.Structure of Brain Plaques in Huntington's Researchers at the University of Pittsburgh School of Medicine have shown that the core of the protein clumps found in the brains of people with Huntington's disease have a distinctive structure, a finding that could shed light on the molecular mechanisms underlying the neurodegenerative disorder. Visualizing a Cancer Drug Target at Atomic Resolution Using cryo-electron microscopy, researchers were able to view, in atomic detail, the binding of a potential small molecule drug to a key protein in cancer cells.Pumpjack" Mechanism for Splitting and Copying DNA High-resolution structural details of cells' DNA-replicating proteins offer new insight into how these molecular machines functionThe Power of Three Overlooked portion of cell “death receptor” critical in some cancers, autoimmune diseases.Biomarker for Recurring HPV-Linked Oropharyngeal Cancers A look-back analysis of HPV infection antibodies in patients treated for oropharyngeal (mouth and throat) cancers linked to HPV infection suggests at least one of the antibodies could be useful in identifying those at risk for a recurrence of the cancer, say scientists at the Johns Hopkins University.